Zurich
Avastin effect confirmed in breast cancer
Submitted by Anonymous on Sun, 2008-12-21 05:25- analyst
- Avastin
- Bevacizumab
- biotechnology
- Breast cancer
- Breast cancer treatment
- Capecitabine
- chemotherapy
- CHF
- Colorectal cancer
- Company Location
- driver
- FDA
- Food and Drug Administration
- forward
- Genentech
- Genentech Inc
- Hal Barron
- Lapatinib
- Martin Voegtili
- Medicine
- Monoclonal antibodies
- Morgan Stanley
- Officer
- Person Career
- Quotation
- Reuters Roche Holding AG
- Sal Oppenheim
- Technology
- Technology
- treatment for cases related to breast cancer
- treatment of metastatic HER2-negative breast cancer
- Vice President
- Zurich
According to a report by the Reuters Roche Holding AG the world's largest maker of cancer drugs said that Avastin or bevacizumab which the company markets with Genentech Inc. met its prime endpoint in a phase III breast cancer trial when it was disclosed that Avastin is in fact effective for breast cancer sufferers as well. The drug is categorized as a "monoclonal antibody" and "anti-angiogenesis" and is the best-selling drug.
- Read more
- 1112 reads
Good news for allergy sufferers: allergy shots much more effective in lymph nodes than in skin
Submitted by Anonymous on Sun, 2008-11-16 07:20- Allergen
- Allergology
- Allergy
- allergy treatment
- Asthma
- chemical
- Co-author
- Disaster
- Disaster
- Entertainment
- Entertainment
- Food allergies
- Food and Drug Administration
- Immune system
- Immunology
- Medical Director
- Medicine
- Peanut
- Person Career
- Pulmonology
- Rhinitis
- Soybean
- Thomas Kundig
- treatment for allergy
- University Hospital of Zurich
- Zurich
An allergy or hypersensitivity is an immune system overreaction to a stimulant. People who suffer from allergy can be sensitive to more than one trigger. Dust mites pollen pet dander or smoke are all frequent allergens. Anything from chlorine to perfume can trigger allergies in sensitive people. Some foods such as peanuts nuts seafood and shellfish can occasionally cause life-threatening allergic reactions in people.
- Read more
- 2126 reads